Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer
- 687 Downloads
The second edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of uterine cervical cancer was published in 2011. The guidelines comprise eight chapters and five algorithms. They were prepared by consensus among the members of the Japan Society of Gynecologic Oncology Guidelines Formulation Committee and Evaluation Committee and are based on a careful review of the evidence obtained from the literature, health insurance system, and actual clinical settings in Japan. The highlights of the 2011 revision are (1) the recommended grades have been changed to five stages—A, B, C1, C2, and D; (2) the revisions are consistent with the new International Federation of Gynecology and Obstetrics staging system; (3) the roles are shared between the ‘Japanese classification of cervical cancer’ and the new guidelines; (4) clinical questions related to adenocarcinoma have been revised; and (5) a clinical question regarding cervical cancer in pregnant patients has been added. Each chapter includes a clinical question, recommendations, background, objectives, explanations, and references. Each recommendation is accompanied by a classification of recommendation categories. The objective of these guidelines is to update the standard treatment strategies for cervical cancer, thus eliminating unnecessary and insufficient treatment.
KeywordsUterine cervical cancer Clinical practice guidelines Surgery Chemotherapy Irradiation Recurrence
We thank the Japan Society of Obstetrics and Gynecology, the Japan Association of Obstetricians and Gynecologists, the Japanese Gynecologic Oncology Group, the Japan Society of Clinical Oncology, and the Japanese Society for Therapeutic Radiology and Oncology for their comments and contributions throughout the project. We also acknowledge support by grants from the Ministry of Health, Labour and Welfare; H24-Clinical Cancer Research-001 (chief researcher, Koichi Hirata).
Conflicts of interest
None of the members of the committee in charge of the preparation of these guidelines has any conflict of interest with entities such as a specific profit or nonprofit organization. The board of the Society Conflict of Interest Committee confirmed the self-reported absence of any conflicts of interest by the Guideline Committee members.
- 1.Gynecologic cancer committee (2012) Gynecologic cancer committee report in 2011. Acta Obstetrica et Gynaecologica Japonica 64:2340–2388Google Scholar
- 2.Cancer mortality in Japan (1958–2012) Center for cancer control and information services, National Cancer Center, Japan. http://ganjoho.jp/professional/statistics/statistics.html. Accessed 15 Sep 2014
- 4.Ariyoshi H (2002) Guideline for correct use of antineoplastic agents (draft). General theory. Gan To Kagaku Ryoho 29:970–977Google Scholar
- 6.Fukui T, Yoshida M, Yamaguchi N (2007) Minds Guidance of practice guidelines 2007. Igakushoin, TokyoGoogle Scholar